Researchers at the Case Western Reserve School of Medicine have found that when compared to seven other anti-diabetic drugs, ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

Research suggests smell training may help improve both cognitive and neuronal functions. Olfactory training could be an ...

The long-time critic at the center of Steven Drukman’s fervent play is at the zenith of her career when memory troubles arise ...

According to a March 2024 Gallup National Health and Well-Being Index survey, an estimated 15.5 million people have used injectable diabetes medications for weight loss, with 3% currently using them ...

If you have thyroid disease, stopping thyroid medications can cause an array of adverse symptoms such as fatigue, hair loss, changes in blood pressure, heart palpitations, and increases or decreases ...

Groundbreaking drugs like Ozempic and Wegovy have been helping people lose weight, but most employers' health plans don't cover the expensive weight loss drugs. NPR pharmaceuticals correspondent ...

Insurance coverage for GLP-1 drugs for the use of weight loss varies by plan. Some insurance companies and employers have refused to cover the medication due to their high cost.

Semaglutide – the drug in medications like Ozempic and Wegovy – causes mice to exercise less. The finding suggests these weight-loss medications may reduce people’s motivation to work out.

Novo Nordisk's weight-loss drug Wegovy will be available in France ... He says that the latest class of drugs is a useful tool for people who have a moderate amount of weight to lose.

Dementia is a devastating disease that impacts one in 10 older Americans ... structural changes in the brain “which may worsen memory loss,” says Clifford Segil, DO, neurologist at Providence ...